Literature DB >> 30666268

Genetic Analysis of KRT9 Gene Revealed Previously Known Mutations and Genotype-Phenotype Correlations in Epidermolytic Palmoplantar Keratoderma.

Yuwei Li1,2, Lili Tang1,2, Yang Han1,2, Liyun Zheng1,2, Qi Zhen1,2, Sen Yang1, Min Gao1.   

Abstract

Epidermolytic palmoplantar keratoderma (EPPK, OMIM 144200) is an autosomal dominant inherited disease, clinically characterized by diffuse yellowish thickening of the skin on the palms and soles, usually with erythematous borders developing during the first weeks or months after birth. Pathogenesis of EPPK is determined by mutations in the keratin gene (KRT9). Thirty three mutations in the KRT9 gene from 100 EPPK families have been identified. Among these, 23 mutations are located in the 1A region (a mutation hot spot region), 7 are located in the 2B region, and the remaining 3 are synonymous mutations. In this study, three heterozygous mutations (p.N161S, p.R163W, and p.R163Q), located in regions of the gene encoding the conserved central a-helix rod domain, were detected in the KRT9 gene of the three large Chinese families. This study confirms that codon 163 (48 of 100 cases) is a hot spot mutation site for KRT9. Additional findings identified p.N161S (4%) and p.R163W (4%) as potential hot spot mutations for EPPK associated with knuckle pads, and p.R163Q (15 of 100 cases) as the hot spot mutation of EPPK not occurring in combination with knuckle pads. In conjunction with future studies, this research may help lay the foundation for genetics counseling, prenatal diagnosis and clinical treatment of EPPK.

Entities:  

Keywords:  KRT9 gene; epidermolytic palmoplantar keratoderma; gene mutation; hot spot; knuckle pads

Year:  2019        PMID: 30666268      PMCID: PMC6330350          DOI: 10.3389/fgene.2018.00645

Source DB:  PubMed          Journal:  Front Genet        ISSN: 1664-8021            Impact factor:   4.599


Background

Epidermolytic palmoplantar keratoderma (EPPK, OMIM 144200), also known as Vorner's palmoplantar keratosis, is an autosomal dominant inherited disease characterized by diffuse, yellow thickening of the palm and sole with an erythematous margin. It was first described in 1901 by Vorner. The incidence rate is approximately 2.2 to 4.4 per 100 000 live newborns (Bonifas et al., 1994; Covello et al., 1998; Smith, 2003; Lopez-Valdez et al., 2013; Liu et al., 2014). Some patients may have hyperhidrosis, knuckle pads, camptodactyly and digital mutilation (Lu et al., 2003; Du et al., 2011; Umegaki et al., 2011). Female patients may have an increased risk for ovarian cancer or breast cancer (Hamada et al., 2013). Keratin 9 is composed of the functional head domain, the functional α-helical domain and the functional tail domain, and is expressed only in the suprabasal layers of the palmoplantar epidermis (Uitto et al., 2007). To date, domestic and foreign scholars have found 33 KRT9 gene mutations in 100 EPPK families, of which 15 cases are associated with knuckle pads. There is no report making a detailed summary and analysis. In this study, cases of EPPK were analyzed to look for genotype-phenotype correlations by searching the database and consulting the literatures, providing a theoretical basis for the prenatal diagnosis of, genetic counseling for, and clinical treatment of EPPK.

Compliance With Ethical Standards

All procedures performed in studies involving human participants were in accordance with the ethical standards of the institutional and/or national research committee and with the 1964 Helsinki declaration and its later amendments or comparable ethical standards. Informed written consents were obtained from all individual participants or their legal representatives (parents) included in the study. The study was approved without restrictions by the Medical Ethics Committee of the First Affiliated Hospital of Anhui Medical University. The probands and their family members provided written informed consent for the publication of this case report.

Case Presentation

Three unrelated Chinese EPPK pedigrees from Shandong and Anhui Province were investigated. All patients exhibited typical EPPK features. There were no close relatives bettwen these families. Family 1 was a six generational EPPK pedigree with 17 affected members, including 11 males and 6 females. The minimum age of onset is 1 year of age. The proband was a 42-year-old man who presented with diffuse thickening and hyperkeratosis on palms with the nails being normal, and combined knuckle pads, hyperhidrosis and camptodactyly (Figures 1A, 2A). There is no evidence that the proband was associated with other diseases. Family 2 was a 4 generational EPPK pedigree with 11 affected members, and the 20-year-old female proband presented with diffuse thickening and hyperkeratosis on palms and soles (Figures 1B, 2B). Family 3 was a 5 generational EPPK pedigree with 10 affected members, and the proband was a 42-year-old man who demonstrated hyperkeratosis of both palmar and plantar skin within 1 year of birth (Figures 1C, 2C).
Figure 1

Pedigrees of EPPK families 1 (A), 2 (B), and 3 (C). Arrows show the probands.

Figure 2

Clinical representations of the proband. (A) Knuckle pads on the dorsal aspect of the proband's hands. (B) Diffuse hyperkeratosis of the proband's palms and soles. (C) Well-demarcated erythematous border of the proband's.

Pedigrees of EPPK families 1 (A), 2 (B), and 3 (C). Arrows show the probands. Clinical representations of the proband. (A) Knuckle pads on the dorsal aspect of the proband's hands. (B) Diffuse hyperkeratosis of the proband's palms and soles. (C) Well-demarcated erythematous border of the proband's.

Laboratory Investigations

Genetic Testing and Confirmation of Mutation

Peripheral blood samples were collected from members of the three families and 100 healthy unrelated Chinese individuals. Genomic DNA was extracted using a Flexi Gene DNA Kit (250). The primers were amplified by polymerase chain reaction (PCR) and PCR products were directly sequenced by an ABI3730 DNA Sequencer (ABI, USA). The sequence was analyzed by Chromas 2.0 software.

Identification of Three Distinct Mutations in the KRT9 Gene of Three Large Chinese Families

Patients of family 1 had a heterozygous mutation c.482A>G (P.Asn161His) in KRT9 gene (Figure 3A). Patients of family 2 had a heterozygous mutation c.487C>T (p.Arg163Trp) in KRT9 gene (Figure 3B). Patients of family 3 had a heterozygous mutation c.488G>A (p.Arg163Gln) in KRT9 gene (Figure 3C).These mutations were not found in normal members of three families and in 100 healthy controls.
Figure 3

(A) Heterozygous variants c.482A>G identified in Family PPK-1. (B) Heterozygous variants c.487C>T identified in Family PPK-2. (C) Heterozygous variants c.488G>A identified in Family PPK-3.

(A) Heterozygous variants c.482A>G identified in Family PPK-1. (B) Heterozygous variants c.487C>T identified in Family PPK-2. (C) Heterozygous variants c.488G>A identified in Family PPK-3.

Genetic Characteristics of the Mutation in the KRT9 Gene

This study searched the human intermediate filament database (http://www.interfil.org/index.php), PubMed (https://www.ncbi.nlm.nih.gov/pubmed), China National Knowledge Internet (http://www.cnki.net/), and a large portion of literature and found that 33 KRT9 gene mutations were reported in 100 EPPK families by domestic and foreign scholars (Table 1). Disease causing mutations are as follows: of which 23 are located in the 1A region (hot spot mutation region), 7 in the 2B region, and the remaining 3 are synonymous mutations. Missense mutations at amino acid 163 (48% of all mutations) is indeed a hot spot mutation site for KRT9. We also found that the mutations of EPPK associated with knuckle pads (15% of 100 cases) are p.N161S (4%), p.R163W (4%), p.L168S (3%), p.M157T (1%), p.L160F (1%), p.C406R (1%), and p.L458p (1%). Since these mutations are the most prevalent we can suggest that p.N161S and p.R163W are potential hot spot mutations of EPPK associated with knuckle pads. The hot spot mutation of EPPK not associated with knuckle pads is p.R163Q (15 of 100 cases).
Table 1

Mutations analysis in KRT9 gene of EPPK.

NoNucleotide changeAmino acid changesDomainClinical symptomsNumber of reported casesReferences
1c.31T>G; 31_516delp.Leu11Val; Leu11_Gln172 delhead, 1AEPPK1Fuchs-Telem et al., 2013
2c.469A>Gp.Met157Val1AEPPK2Hennies et al., 1994
2Covello et al., 1998
1Rugg et al., 2002
3c.470T>Cp.Met157Thr1AEPPK without knuckle pads1Covello et al., 1998
1Shimomura et al., 2010
EPPK with knuckle pads1Chen et al., 2009
4c.470T>Gp.Met157Arg1AEPPK1Shimazu et al., 2006
1Zhao et al., 2008
1Liang et al., 2014
5c.470T>Ap.Met157Lys1AEPPK1Shimomura et al., 2010
6c.478C>Gp.Leu160Val1AEPPK1(Endo and Hatamochi, 1997)
7c.478C>Tp.Leu160Phe1AEPPK with knuckle pads1Lu et al., 2003
8c.481A>Tp.Asn161Tyr1AEPPK1Torchard et al., 1994
9c.481A>Cp.Asn161His1AEPPK1Lee et al., 2003
1Lin et al., 2004
10c.482A>Gp.Asn161Ser1AEPPK without knuckle pads1Bonifas et al., 1994
1Amichai et al., 2002
1Lee et al., 2003
1Liu et al., 2014
1Mao et al., 2018
EPPK with knuckle pads1Tsunemi et al., 2002
1Zhang et al., 2004
1Hamada et al., 2005
1Yin et al., 2007
11c.482A>Tp.Asn161Ile1AEPPK1Kuster et al., 2002
1Csikós et al., 2003
12c.483T>Ap.Asn161Lys1AEPPK1Reis et al., 1994
13c.484C>Tp.Pro162Ser1AEPPK1Li et al., 2008
14c.484T>Cp.Ser162Pro1AEPPK1Zeng et al., 2017
15c.487C>Tp.Arg163Trp1AEPPK without knuckle pads3Reis et al., 1994
1Bonifas et al., 1994
2Navsaria et al., 1995
1Rothnagel et al., 1995
1Yang et al., 1998
1Mayuzumi et al., 1999
1Morgan et al., 1999
1Warmuth et al., 2000
1Rugg et al., 2002
1Yang et al., 2003
3Lee et al., 2003
3Terrinoni et al., 2004
1Funakushi et al., 2009
1Umegaki et al., 2011
2Liu et al., 2012
1Guo et al., 2014
2Ke et al., 2014
1Wang et al., 2016
EPPK with knuckle pads1Mao et al., 2018
1Chiu et al., 2007
1Codispoti et al., 2009
1Lopez-Valdez et al., 2013
16c.488G>Ap.Arg163Gln1AEPPK1Reis et al., 1994
1Kobayashi et al., 1996
1Yang et al., 1998
1Covello et al., 1998
1Szalai et al., 1999
1Rugg et al., 2002
1Wennerstrand et al., 2003
1Yang et al., 2003
1Sun et al., 2005
2Shimomura et al., 2010
1Li et al., 2012
1Ke et al., 2014
1Zhang et al., 2016
1Mao et al., 2018
17c.488G>Cp.Arg163Pro1AEPPK1Kon et al., 2006
18c.491T>Cp.Leu164Pro1AEPPK1Mao et al., 2018
19c.500_500delAinsGGCTp.Tyr167delinsTrpLeu1AEPPK1He et al., 2004
3Zhang et al., 2005
20c.503T>Cp.Leu168Ser1AEPPK with knuckle pads1Rothnagel et al., 1995
1Yin et al., 2007
1Li et al., 2009
21c.508A>Tp.Lys170X1AEPPK1Szalai et al., 1999
22c.511G>Ap.Val171Met1AEPPK1Rugg et al., 2002
23c.515A>Cp.Gln172Pro1AEPPK1Hennies et al., 1994
24c.1216T>Cp.Cys406Arg2BEPPK with knuckle pads1Wang et al., 2010
25c.1282C>Tp.Gln428X2BEPPK1Umegaki et al., 2011
26c.1360T>Cp.Tyr454His2BEPPK1Shimomura et al., 2010
27c.1362_1363insCACp.Tyr454_His 455insHis2BEPPK1Coleman et al., 1999
28c.1369C>Tp. Leu457Phe2BEPPK1Xiao et al., 2018
29c.1372C>Tp.Leu458Phe2BEPPK1Kon et al., 2006
30c.1373 T >Cp.L458P2BEPPK with knuckle pads1Du et al., 2011

3 synonymous mutations are not listed.

Mutations analysis in KRT9 gene of EPPK. 3 synonymous mutations are not listed.

Discussion

Epidermolytic palmar hyperkeratosis (EPPK) is rare in clinical settings with a prevalence of ~4.4/100,000. In mild cases, only the epidermis of the palmoplantar is rough, and severe horny thickening plaques appear in the palmoplantar region. It may even spread to the lateral edge of the palmoplantar skin or the hands and feet and may be accompanied by knuckle pads and finger-toe flexion deformities. The keratin mutations that have been found so far are concentrated in the 1A helix region and the 2B helix region, namely, the KRT9 gene mutation hot spot (Guo et al., 2014; Liang et al., 2014), especially the 1A region, which affects the formation of keratinous network structures leading to severe clinical manifestations. Researchers at home and abroad have found that the 163rd amino acid is the hotspot mutation region of the KRT9 gene (48 of 100 cases) (Rugg et al., 2002). EPPK combined with knuckle pads maybe associated with mutations in many KRT9 genes, such as p.Met157Thr, p.Leu160Phe, p.Asn161Ser,p.Arg163Trp, p.Leu168Ser, p.Cys406Arg, and p.Leu458Pro (Escobar et al., 2007; Codispoti et al., 2009; Li et al., 2009; Wang et al., 2010; Du et al., 2011; Mao et al., 2018; Xiao et al., 2018). In this study, we studied three large Chinese families with EPPK and found 3 heterozygous gene mutations of KRT9: c.482A>G (p.Asn161Ser), c.487C>T (p.Arg163Trp) and c.488G>A (p.Arg163Gln).These mutations were not found in normal members of three families and in 100 healthy controls, indicating that the mutations detected in the families were the pathogenic mutations. The mutation p.Asn161Ser has been reported several times in relation to the typical hyperkeratotic manifestations of palmoplantar skin in patients with EPPK, but it has not been associated with other clinical phenotypes. In 2005, Japanese scholars reported a case of EPPK in a 13-year-old patient with knuckle pads, and the genetic test results were found to be associated with the mutation p.Asn161Ser. In this study, the pathogenic mutation of family 1 was p.Asn161Ser, and all patients in the family showed knuckle pads, consistent with previous reports. This study found that 33 KRT9 gene mutations in 100 EPPK families have been reported by domestic and foreign scholars, and the mutations of EPPK associated with knuckle pads (15 of 100 cases) are p.N161S (4%), p.R163W (4%), p.L168S (3%), p.M157T (1%), p.L160F (1%), p.C406R (1%), and p.L458p (1%), suggesting p.N161S and p.R163W are potential hot spot mutations of EPPK associated with knuckle pads, and p.R163Q (15 of 100 cases) as the hot spot mutation of EPPK not occurring in combination with knuckle pads.Based on the above studies, this case reveals knuckle pads may also be one of the less common clinical phenotypes of EPPK, and we think this study should help lay the foundation for genetics counseling, prenatal diagnosis and clinic treatment of EPPK.

Author Contributions

All authors listed have made a substantial, direct and intellectual contribution to the work, and approved it for publication.

Conflict of Interest Statement

The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.
  2 in total

1.  Detecting tandem repeat variants in coding regions using code-adVNTR.

Authors:  Jonghun Park; Mehrdad Bakhtiari; Bernt Popp; Michael Wiesener; Vineet Bafna
Journal:  iScience       Date:  2022-07-19

Review 2.  Keratin 9 L164P mutation in a Chinese pedigree with epidermolytic palmoplantar keratoderma, cytokeratin analysis, and literature review.

Authors:  Xiaoliang Liu; Chuang Qiu; Rong He; Yuanyuan Zhang; Yanyan Zhao
Journal:  Mol Genet Genomic Med       Date:  2019-09-16       Impact factor: 2.183

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.